Boston Scientific Insider Sold Shares Worth $13,775,792, According to a Recent SEC Filing-July 2024-www.financetom.com

Boston Scientific Insider Sold Shares Worth $13,775,792, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Boston Scientific Insider Sold Shares Worth $13,775,792, According to a Recent SEC Filing

Oct 10, 2024 9:44 PM

05:53 PM EDT, 10/08/2024 (MT Newswires) -- Michael F Mahoney, Director, Chairman, President & CEO, on October 07, 2024, sold 162,777 shares in Boston Scientific ( BSX ) for $13,775,792. Following the Form 4 filing with the SEC, Mahoney has control over a total of 1,781,374 shares of the company, with 1,572,096 shares held directly and 209,278 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/xslF345X05/doc4.xml

Price: 86.01, Change: +0.17, Percent Change: +0.20

Previous page： Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced Next page： Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced

Sep 2, 2025

11:25 AM EDT, 09/02/2025 (MT Newswires) -- (Updates to include Arrowhead's stock movement in the headline and the first paragraph.) Arrowhead Pharmaceuticals ( ARWR ) shares rose 9.2% in recent Tuesday trading after the company announced a global licensing and collaboration agreement for its ARO-SNCA preclinical stage siRNA therapy to treat synucleinopathies, including Parkinson's disease, with Novartis ( NVS )...

Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing

Sep 2, 2025

11:25 AM EDT, 09/02/2025 (MT Newswires) -- Phil Horlock, Director, on August 28, 2025, sold 13,000 shares in Blue Bird ( BLBD ) for $767,260. Following the Form 4 filing with the SEC, Horlock has control over a total of 240,766 common shares of the company, with 240,766 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1589526/000157947725000018/xslF345X05/wk-form4_1756826178.xml Price: 57.75, Change: -0.64, Percent Change:...

Update: Ionis Pharma Shares Rise After Reporting 'Positive' Olezarsen Data in Severe Hypertriglyceridemia

Sep 2, 2025

11:26 AM EDT, 09/02/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.) Ionis Pharmaceuticals ( IONS ) shares were up more than 33% in recent Tuesday trading after the company reported topline data from phase 3 studies of olezarsen, which showed that the drug candidate significantly reduced fasting triglycerides and acute pancreatitis events in...

Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal

Sep 2, 2025

Nukkleus Inc. ( NUKK ) shares soared on Tuesday after the company said it will acquire Israel-based Tiltan Software Engineering Ltd. in a $14 million deal. The acquisition, to be paid in a mix of cash and stock, is expected to close following regulatory approval and audited financials. The announcement underscores growing demand for AI-powered simulation and GPS-denied navigation tools...